Related references
Note: Only part of the references are listed.Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model
Maaike V. J. Braham et al.
ONCOIMMUNOLOGY (2018)
CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells
Mateusz Legut et al.
BLOOD (2018)
Automated Manufacturing of Potent CD20-Directed Chimeric Antigen Receptor T Cells for Clinical Use
Dominik Lock et al.
HUMAN GENE THERAPY (2017)
Integration of a CD19 CAR into the. TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells
Daniel T. MacLeod et al.
MOLECULAR THERAPY (2017)
Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation
Siyi Gu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Global Manufacturing of CAR T Cell Therapy
Bruce L. Levine et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Single-cell multiplexed cytokine profiling of CD19 CAR-T cells reveals a diverse landscape of polyfunctional antigen-specific response
Qiong Xue et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
Rebecca A. Gardner et al.
BLOOD (2017)
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
D. Sommermeyer et al.
LEUKEMIA (2016)
RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor
Zsolt Sebestyen et al.
CELL REPORTS (2016)
Untouched GMP-Ready Purified Engineered Immune Cells to Treat Cancer
Trudy Straetemans et al.
CLINICAL CANCER RESEARCH (2015)
Hunting for clinical translation with innate-like immune cells and their receptors
W. Scheper et al.
LEUKEMIA (2014)
Manufacture of Gene-Modified Human T-Cells with a Memory Stem/Central Memory Phenotype
Raquel Gomez-Eerland et al.
HUMAN GENE THERAPY METHODS (2014)
Multifunctional γδ T cells and their receptors for targeted anticancer immunotherapy
Wouter Scheper et al.
ONCOIMMUNOLOGY (2013)
γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs
Cordula Gruender et al.
BLOOD (2012)
Redirecting αβT cells against cancer cells by transfer of a broadly tumor-reactive γδT-cell receptor
Victoria Marcu-Malina et al.
BLOOD (2011)
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
Renier J. Brentjens et al.
BLOOD (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Efficient Human Hematopoietic Cell Transduction Using RD114-and GALV-Pseudotyped Retroviral Vectors Produced in Suspension and Serum-Free Media
Karim Ghani et al.
HUMAN GENE THERAPY (2009)
Requirements for effective antitumor responses of TCR transduced T cells
Moniek A. de Witte et al.
JOURNAL OF IMMUNOLOGY (2008)
T-cell receptor gene therapy of established tumors in a murine melanoma model
John D. Abad et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media
K. Ghani et al.
GENE THERAPY (2007)
The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies
Catia Traversari et al.
BLOOD (2007)
CD8(+) T-cell memory in tumor immunology and immunotherapy
Christopher A. Klebanoff et al.
IMMUNOLOGICAL REVIEWS (2006)
Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer
CHJ Lamers et al.
CANCER GENE THERAPY (2002)